Health Populi

OCTOBER 8, 2019

Pricing failure, the second big waste factor, is predominantly challenged by pharmaceutical/prescription drug pricing based on this research. The Centers for Medicare and Medicaid Services (CMS) forecasts that prescription drug spending will be the fastest-growing cause of rising health spending by 2027.

Prescription Drug Pricing 104

Prescription Drug Pricing Medicare Medicare ACA 104

Hall Render

FEBRUARY 24, 2023

NATIONAL Addressing Staff Burnout In Healthcare Design Amazon completes $3.9B Dunleavy adds $9M to budget to address food stamp, Medicaid backlog New study provides snapshot of increase in maternal deaths in Alaska Mental Health Trust Grants $1.6M

Nursing Homes 40

Nursing Homes COVID-19 Nurses Hospitals 40

Health Populi

JANUARY 29, 2019

See the dark blue dot in 2023 north of the other dots, representing the median costs for a non-oncology drug with orphan status priced around $300,000. Other key trends to expect leading to 2023 will be: The rise of patient advocacy roles in pharma companies. Thus far, the FDA has been welcoming to these concepts.

Prescription Drug Pricing 96

Prescription Drug Pricing FDA Patient Advocacy Governance 96